Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer

PURPOSE: Alteration of biomarker status after primary systemic therapy (PST) is occasionally found in breast cancer. This study was conducted to clarify the clinical implications of change of biomarker status in breast cancer patients treated with PST. MATERIALS AND METHODS: The pre-chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Soomin, Kim, Hyun Jeong, Kim, Milim, Chung, Yul Ri, Kang, Eunyoung, Kim, Eun-Kyu, Kim, Se Hyun, Kim, Yu Jung, Kim, Jee Hyun, Kim, In Ah, Park, So Yeon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192918/
https://www.ncbi.nlm.nih.gov/pubmed/29361816
http://dx.doi.org/10.4143/crt.2017.552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192918/
https://www.ncbi.nlm.nih.gov/pubmed/29361816
http://dx.doi.org/10.4143/crt.2017.552

Ejemplares similares